Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

The coronavirus disease‐2019 (COVID‐19) caused by SARS Coronavirus 2 (SARS‐CoV‐2) is a potentially lethal infection. Cancer patients, and specifically hematopoietic cell transplant (HCT) recipients are severely immunocompromised and may be at a higher risk of a complicated course with this infection...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2021-09, Vol.56 (9), p.2144-2151
Hauptverfasser:	El Fakih, Riad, Haroon, Alfadil, Alfraih, Feras, Al-Khabori, Murtadha K., Alzahrani, Mohsen, Alhuraiji, Ahmad, Hamadah, Abdulaziz, AlJohani, Naif I., Alahmari, Bader, Essa, Mohammed F., Motabi, Ibraheem H., Tailor, Imran K., Almaghrabi, Reem S., Al-Farsi, Khalil, Abosoudah, Ibraheem, Ayas, Mouhab, Elhassan, Tusneem A., Suhebeh, Ashraf M., Ahmed, Syed Osman, Alhayli, Saud, Kaloyannidis, Panayotis, Alsaeed, Ahmad, Anezi, Khalid Al, Alamoudi, Sameer, Damlaj, Moussab, Hashmi, Hani Al, Aljurf, Mahmoud
Format:	Artikel
Sprache:	eng
Schlagworte:	631/532/1542 692/699/255 Antibodies Cell Biology Coronaviruses COVID-19 Hematology Hematopoietic Stem Cell Transplantation Hematopoietic stem cells Humans Infections Internal Medicine Mechanical ventilation Medicine Medicine & Public Health Patients Public Health Retrospective Studies SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Stem cell transplantation Stem Cells Supplements Transplant Recipients Transplantation Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!